艾力斯：江苏艾力斯已取得江苏省药品监督管理局GMP符合性证明文件，新生产线获批投产

Group 1 - The new production line for 150 million tablets of Fumagillin solid preparation has commenced production [2] - Ailis (688578.SH) confirmed on the investor interaction platform that it obtained the GMP compliance certificate from the Jiangsu Provincial Drug Administration in July 2025 [2] - The new production line has been approved for production, meeting the licensing conditions set by the drug supervision authorities [2]